Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-054586
Filing Date
2018-10-19
Accepted
2018-10-19 16:53:01
Documents
1
Period of Report
2018-10-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv505080_4.html 4  
1 OWNERSHIP DOCUMENT tv505080_4.xml 4 4248
  Complete submission text file 0001144204-18-054586.txt   5985
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8100 SOUTHPARK WAY, A-8 LITTLETON CO 80120
Business Address
Eansor Norman David (Reporting) CIK: 0001270905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 181130900